# EASEE® System Pivotal Study for the United States of America

> **NCT07301346** · NA · NOT_YET_RECRUITING · sponsor: **Precisis US, Inc.** · enrollment: 200 (estimated)

## Conditions studied

- Drug-Resistant Focal Epilepsy

## Interventions

- **DEVICE:** Implantable minimaly invasive brain stimulator
- **DEVICE:** Implantable minimaly invasive brain stimulator

## Key facts

- **NCT ID:** NCT07301346
- **Lead sponsor:** Precisis US, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2029-07-01
- **Final completion:** 2030-07-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07301346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07301346, "EASEE® System Pivotal Study for the United States of America". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07301346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*